RND - ETF AI Analysis
Top Page
First Trust Bloomberg R&D Leaders ETF (RND)
RND, the First Trust Bloomberg R&D Leaders ETF, earns a solid overall rating largely because it is heavily invested in innovation leaders like Apple, Microsoft, Alphabet, Nvidia, and Micron, all of which show strong financial performance, positive earnings commentary, and promising growth in areas like AI, cloud, and data centers. Some holdings such as Amazon, Tesla, Eli Lilly, AMD, and Broadcom face risks from high valuations, leverage, or mixed technical signals, which can limit upside and add volatility. The main risk factor is the fund’s concentration in a relatively small group of large, growth-focused tech and AI-related companies, making it sensitive to shifts in sentiment or regulation around these sectors.
RND vs. SPDR S&P 500 ETF (SPY)
- AUM
- 9.94M
- Region
- North America
- Expense Ratio
- 0.60%
- Beta
- 1.26
- Issuer
- First Trust
- Inception Date
- Apr 30, 2024
- Dividend Yield
- 0.03%
- Asset Class
- Equity
- Index Tracked
- Bloomberg R&D Leaders Select TR
RND Summary
The First Trust Bloomberg R&D Leaders ETF (RND) follows the Bloomberg R&D Leaders Select index, focusing on companies that spend heavily on research and development to drive future innovation. It mainly holds large U.S. firms in technology and health care, including well-known names like Apple and Microsoft, along with other major tech and pharma leaders. Someone might invest in RND to gain diversified exposure to innovative companies that could benefit from long-term growth driven by new products and technologies. A key risk is that it is heavily tilted toward tech and other growth stocks, so its price can rise and fall sharply with market swings and changes in investor sentiment.
How much will it cost me?
This ETF has an expense ratio of 0.60%, which means you’ll pay about $6 per year for every $1,000 you invest. That’s higher than the average cost for broad, passively managed index ETFs because this fund follows a more specialized strategy focused on R&D leaders, which typically requires more active research and management.
What would affect this ETF?
RND is heavily invested in innovative U.S. technology and health care companies like Amazon, Microsoft, Apple, and Nvidia, so it could benefit if demand for new digital tools, artificial intelligence, and medical breakthroughs stays strong and the U.S. economy remains healthy. On the downside, the fund could be hurt by rising interest rates that pressure growth stocks, tighter regulations on big tech or drug makers, or an economic slowdown that reduces spending on research and development and consumer services.
RND Top 10 Holdings
RND is leaning heavily into U.S. Big Tech and chipmakers, with Apple and Microsoft acting as steady anchors and helping keep the fund on a generally upward path. Amazon has been more of a wobbling wheel lately, with recent trading weakness dulling its impact. Nvidia, AMD, and Micron form the fund’s high-octane semiconductor engine, where AMD and Micron are rising while Nvidia’s momentum looks a bit mixed. Eli Lilly adds a powerful health care growth kicker, while Tesla’s rebound is helping offset earlier drag, all within a U.S.-centric innovation story.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 AAPL | Apple | 8.56% | $832.97K | $5.03T | 26.98% | 79Outperform |
 MSFT | Microsoft | 8.42% | $819.40K | $3.88T | -0.73% | 79Outperform |
 AMZN | Amazon | 7.98% | $776.57K | $2.59T | 7.85% | 71Outperform |
 NVDA | Nvidia | 7.41% | $721.36K | $4.93T | 0.86% | 76Outperform |
 GOOGL | Alphabet Class A | 6.73% | $654.83K | $3.41T | -0.58% | 85Outperform |
 LLY | Eli Lilly & Co | 5.07% | $493.30K | $1.33T | 67.86% | 72Outperform |
 TSLA | Tesla | 4.66% | $453.38K | $1.58T | -9.15% | 73Outperform |
 AVGO | Broadcom | 3.84% | $373.69K | $1.56T | -13.38% | 76Outperform |
 AMD | Advanced Micro Devices | 3.41% | $332.16K | $824.07B | 98.09% | 73Outperform |
 MU | Micron | 3.44% | $334.43K | $1.00T | 294.96% | 79Outperform |
RND Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RND, the sentiment is Negative. The current price of 32.42 is below the 20-day moving average (MA) of 33.52, below the 50-day MA of 33.25, and above the 200-day MA of 31.22, indicating a neutral trend. The MACD of -0.14 indicates Positive momentum. The RSI at 38.89 is Neutral, neither overbought nor oversold. The STOCH value of 44.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RND.
RND Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| RND | $32.42 | $37.00(14.12% Upside) | $9.94M | 0.60% | 76Outperform |
 BUZZ | $32.98 | $51.61(56.49% Upside) | $91.89M | 0.76% | 65Neutral |
 STNC | $37.32 | $42.62(14.20% Upside) | $93.14M | 0.85% | 68Neutral |
 SOVF | $31.63 | $37.40(18.24% Upside) | $90.20M | 0.75% | 70Neutral |
 PFOE | $21.63 | $29.13(34.68% Upside) | $88.71M | 0.59% | 75Outperform |
 VAMO | $36.31 | $42.55(17.18% Upside) | $87.92M | 0.65% | 63Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| RND | First Trust Bloomberg R&D Leaders ETF | 32.42 | 1.28 | 4.11% | |
| BUZZ | VanEck Social Sentiment ETF | 32.98 | -4.64 | -12.33% | |
| STNC | Stance Equity ESG Large Cap Core ETF | 37.32 | 5.00 | 15.49% | |
| SOVF | Sovereign's Capital Flourish Fund | 31.63 | 3.21 | 11.29% | |
| PFOE | Pathfinder Focused Opportunities ETF | 21.63 | -3.23 | -13.00% | |
| VAMO | Cambria Value & Momentum ETF | 36.31 | 3.71 | 11.37% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.